3Fernandez-Seara J, Prieto J, Quiroga J, ct al. Systemic and regional hemodynamics in patients with liver cirrhosis and ascites with and without functional renal failure. Gastroenterology, 1989, 97: 1304- 1312.
4Salerno F, Gerbes A, Gines P, et al. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut, 2007, 56: 1310- 1318.
5Fernandez J, Monteagudo J, Bargallo X, et al. A randomized unblinded pilot study comparing albumin versus hydroxyethyl starch in spontaneous bacterial peritonitis. Hepatology, 2005, 42: 627-634.
6Sanyal A J, Boyer T, Garcia-Tsao G, et al. A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome. Gastroenterology, 2008, 134:1360-1368.
7Solanki P, Chawla A, Garg R, et al. Beneficial effects of terlipressin in hepatorenal syndrome: a prospective, randomized placebo-controlled clinical trial. J Gastroenterol Hepatol, 2003, 18: 152-156.
8Chen R.[J]. J Electrochem Soc, 1969, 116: 1254.
9Jahan M S, Cooke D W, Hults W L.[J]. J Luminesc, 1990, 47: 85.
10Cooke D W, Bennett B L, Farnum E H, et al.[J]. Appl Phys Lett, 1997, 70: 3594.
